Management of the PDA Trial

Running, not enrolling · Phase 3

Conditions studied: Infant, Premature, Patent Ductus Arteriosus, Infant, Newborn, Diseases, Patent Ductus Arteriosus After Premature Birth

In brief

Estimate the risks and benefits of active treatment versus expectant management of a symptomatic patent ductus arteriosus (sPDA) in premature infants.

Key facts

Study ID
NCT03456336
Run by
NICHD Neonatal Research Network
People needed
482
Starts
2019-02-22
Expected to finish
2027-05-30
Last updated by the study team
2026-05-12

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.